Clinical Trial Update: Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a Korean botulinum toxin type A formulation to Botox for essential blepharospasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Korean Botulinum Toxin Type A (botulinum toxin type A)

Snippet

Sponsor: Pacific Pharmaceuticals | Conditions: Blepharospasm | Phase 3 | Status: COMPLETED